Kingston Health Sciences Centre is looking for participants for a new study examining how psilocybin the active ingredient in magic mushrooms could help treat anxiety. The two month study will test whether small, controlled micro-doses of the psychedelic drug can reduce anxiety symptoms in patients.
Health
Kingston Health Sciences Centre using psilocybin to treat anxiety
More Videos
-
Health Matters: Ontario hospitals ask for an additional $1.1B in funding
-
Beyond sleeping pills: A new model for insomnia care in Canada
-
Kingston man shares his struggles with homelessness through social media
-
London Health Sciences Centre clinical trial targets kidney cancer with internal radiation
-
Emergency room closures drop in Ontario as critics urge government to make data public
You are viewing an .
View Original Article